FairScope Lab
EN 繁中 简中

JNJ

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-06-30

P/E Ratio · Metrics

P/E Ratio

28.00

PEG Ratio

0.42

Dividend Yield

-

Gross Margin

73.11%

Net Margin

21.86%

Revenue CAGR 3Y

5.56%

ROE

26.05%

ROA

11.01%

Buyback Yield

0.21%

Current Ratio

1.09

Magic Earn Yield

-

Altman Z-Score

-

Fair Value River

Score

Valuation 65
Profitability 53
Growth 19
Health 36
Yield 3
← Back to Dashboard